Successful management of therapy‐related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil-Reference-Cited by-同舟云学术

Successful management of therapy‐related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil

Published:2021-06 Issue:6 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Nakako Soichiro¹,Takakuwa Teruhito¹^ORCID,Ichimura Hirona¹,Okamura Hiroshi¹,Nanno Satoru¹,Nishimoto Mitsutaka¹,Nakashima Yasuhiro¹,Koh Hideo¹,Hino Masayuki¹,Nakamae Hirohisa¹

Affiliation:

1. Department of Hematology Graduate School of Medicine Osaka City University Osaka Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4298

Reference15 articles.

1. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

3. Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia

4. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

5. Myelodysplastic Syndrome/Acute Myelogenous Leukaemia Related To Adjuvant Chemotherapy With Oral Pyrimidine Anti-Metabolites

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Antineoplastics;Reactions Weekly;2022-09-17